| Title |
Phase II study of CCI-779 in patients with recurrent glioblastoma multiforme
|
|---|---|
| Published in |
Investigational New Drugs, August 2005
|
| DOI | 10.1007/s10637-005-1444-0 |
| Pubmed ID | |
| Authors |
Susan M. Chang, Patrick Wen, Timothy Cloughesy, Harry Greenberg, David Schiff, Charles Conrad, Karen Fink, H. Ian Robins, Lisa De Angelis, Jeffrey Raizer, Kenneth Hess, Ken Aldape, Kathleen R. Lamborn, John Kuhn, Janet Dancey, Michael D. Prados, North American Brain Tumor Consortium and the National Cancer Institute |
Mendeley readers
The data shown below were compiled from readership statistics for 92 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Mexico | 1 | 1% |
| Brazil | 1 | 1% |
| Unknown | 90 | 98% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 13 | 14% |
| Student > Ph. D. Student | 10 | 11% |
| Professor > Associate Professor | 9 | 10% |
| Student > Master | 9 | 10% |
| Student > Postgraduate | 8 | 9% |
| Other | 23 | 25% |
| Unknown | 20 | 22% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 23 | 25% |
| Agricultural and Biological Sciences | 18 | 20% |
| Biochemistry, Genetics and Molecular Biology | 12 | 13% |
| Neuroscience | 6 | 7% |
| Pharmacology, Toxicology and Pharmaceutical Science | 5 | 5% |
| Other | 5 | 5% |
| Unknown | 23 | 25% |
Attention Score in Context
This research output has an Altmetric Attention Score of 6. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 09 August 2022.
All research outputs
#4,764,956
of 23,053,169 outputs
Outputs from Investigational New Drugs
#166
of 1,175 outputs
Outputs of similar age
#10,515
of 57,587 outputs
Outputs of similar age from Investigational New Drugs
#4
of 8 outputs
Altmetric has tracked 23,053,169 research outputs across all sources so far. Compared to these this one has done well and is in the 76th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,175 research outputs from this source. They receive a mean Attention Score of 4.7. This one has done well, scoring higher than 79% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 57,587 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 71% of its contemporaries.
We're also able to compare this research output to 8 others from the same source and published within six weeks on either side of this one. This one has scored higher than 4 of them.